Each individual's intestinal microbiome is unique. More than 70 percent of our body's immune cells are distributed around the intestines, where intestinal microbiomes symbiotics the immune cells, helping to digest food, preventing the infiltration of harmful bacteria, and controlling our body's immune system.
Post-Synergy is a personalized healthcare service that analyzes the types and proportions of intestinal microbiomes through intestinal microbial genetic testing (NGS), metabolic testing(GC) and PMAS analysis to check the appropriateness of microbial levels in certain diseases and provide personalized postbiotics to individuals.
NGS : Provide the presence or absence of microorganisms-related diseases and harmful microorganisms
GC : Identify substances produced by microorganisms to provide more accurate intestinal environment information
PMAS : Provide optimized solutions for individuals to improve the intestinal environment effectively
Basic : NGS
Premium: NGS + GC + PMAS
In the study of various diseases and therapeutic purposes, experimental design is one of the most important part.
For a variety of partners who are struggling in their research, HEM will provide continuous technology support and research solutions tailored to you.
- Obesity and diabetes
- Inflammatory bowel disease(IBD) & Irritable bowel syndrome(IBS)
- Skin microbiome
- Gut-brain axis
- Lung microbiome
- Next generation probiotics
- Metabolite profiling of whole microbiome metabolites
- Metabolic pathway analysis
- Noble biomarkers
- Skin, gut, liver, intestine, and other tissues
- Plasma, serum, urine, feces, and other biofluid samples
- Short-chain fatty acids
- Bile acids
- Vitamin B series
- Other customized markers
According to the research goals to be commissioned, decide the experiment direction through customized consulting.
Please send us the sample for the research. To protect the sample, enclose it with dry ice.
* Please be extra careful with the sample condition, since it might interfere the result.
Experiment and analyze according to the direction and goals of your research.
Deliver the result and follow up with the customer’s feedback.
OHMYGUT service analyzes individual gut microbiota to look for a personalized solution.
Our patent application technology, Pharmaceutical Meta-Analysis Screening (PMAS), extracts gut microbiota from fecal samples, and replicates them to test what solutions are needed to implement to transform intestinal microorganisms into healthy environments.
A basic service that provides basic information about gut microbiome
A premium service that provides PMAS analysis
The service not only provides probiotics as a supplement food, but also suggests the most suitable probiotics from the results of the PMAS, such as the comprehensive score of intestinal health and the intestinal health age through the analysis of intestinal microorganisms, and, then optimized solution is provided to individuals to enable effective gut microbiota recovery based on the results.